Live feed
Filing
SC 13G/A
SC 13G/A0001274173-24-000020·AN2 Therapeutics, Inc.
Schedule 13G ownership disclosure
AN2 Therapeutics, Inc.
Security class unavailable · CUSIP: 037326105
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,279,975
- Percent of class
- 4.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000020
- Form type
- SC 13G/A
- Filer
- AN2 Therapeutics, Inc.
- CIK
- CIK 1880438
- Filed
- Feb 12, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership